This review assessed interventions used by community psychiatric services to reduce nonadherence with medication and appointments in patients with psychosis or schizophrenia. The authors concluded that community psychiatric services can provide effective clinical interventions to reduce patient non-adherence. The lack of a validity assessment and the poor reporting of the review process make it difficult to comment on the strength of the evidence or the authors' conclusions.
Two reviewers independently extracted the data using a data extraction form. The extracted data included study setting, study design, the number of patients in each treatment group, the length of follow-up, characteristics of the patients and interventions, the number of patients analysed, definition of nonadherence, and results.
Results reported as percentages were converted to absolute numbers. For each study, the odds ratio (OR) and 95% confidence interval (CI) were calculated for dichotomous data and the standardised mean difference (SMD) was calculated for continuous data. The review classified methods used to assess the outcomes into four categories: patient interview, case-note evaluation, rating scale, and urine test.
Methods of synthesis
How were the studies combined? Studies with adequate outcome data were combined using a random-effects model for the meta-analysis. Pooled weighted ORs (with 95% CIs) and pooled SMDs (with 95% CIs) were calculated. A funnel plot was used to assess publication bias.
How were differences between studies investigated?
Statistical heterogeneity was assessed using the chi-squared statistic. A subgroup analysis was used to assess the influence on the results of: study design (RCT or CCT); the length of follow-up (shorter or longer than 6 months); diagnosis (schizophrenia or severe mental disorders); type of intervention; outcome (nonadherence to medication or appointments); and study setting (in-patients, out-patients, or hospital discharge). Meta-regression was also used to explore the influence of these study characteristics on the results.
Results of the review
Forty-seven studies met the inclusion criteria, but only 24 studies were included in the meta-analysis. These 24 studies comprised 14 RCTs (n=1,548) and 10 CCTs (n=2,030). The number of patients per study ranged from 21 to 660.
Overall studies: the interventions significantly reduced nonadherence compared with control. The pooled OR (19 studies) was 2.59 (95% CI: 2.21, 3.03); statistically significant heterogeneity was found (P<0.001). The pooled SMD (5 studies) was 0.36 (95% CI: 0.06, 0.66); no statistically significant heterogeneity was found (P=0.274).
The funnel plot was asymmetrical, suggesting the possibility of publication bias.
The meta-regression showed a greater effect with a shorter length of treatment and an increased effect in patients with schizophrenia. Other factors were not significantly associated with treatment effect. The results were reported.
Implications of the review for practice and research
Practice: The authors stated that until long-term results are available, clinical interventions should be implemented as short-term measures. They recommended that pre-discharge contracts between patients and the out-patient team, or predischarge psychotherapeutic programmes, should become part of routinely delivered service policy and be offered each time patients are scheduled for discharge.
Research: The authors stated that large, well-conducted experimental studies are required to assess the long-term effectiveness of educational strategies, psychotherapeutic programmes and specific service policies in patients recruited from a wide variety of settings. They stated that patients with schizophrenia should be studied separately. Trials should be well reported; in particular, reports should detail exclusion rates, reasons for exclusion, the proportion of patients not adhering to treatment at the end of the acute phase and the proportion remaining adherent at follow-up, and results reported as absolute numbers and outcomes reported for intention-to-treat and completer samples.
